CARE Ratings Limited
NSE:CARERATING.NS
1509.75 (INR) • At close November 4, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 3,316.848 | 2,789.93 | 2,469.643 | 2,391.301 | 2,436.403 | 3,189.691 | 3,326.841 | 2,874.319 | 2,793.668 | 2,605.498 | 2,355.887 | 2,030.324 | 1,795.72 |
| Cost of Revenue
| 2,300.334 | 1,339.437 | 1,122.161 | 1,078.184 | 960.907 | 855.278 | 722.65 | 725.594 | 756.325 | 747.1 | 632.442 | 522.111 | 386.819 |
| Gross Profit
| 1,016.514 | 1,450.493 | 1,347.482 | 1,313.117 | 1,475.496 | 2,334.413 | 2,604.191 | 2,148.725 | 2,037.343 | 1,858.398 | 1,723.445 | 1,508.213 | 1,408.9 |
| Gross Profit Ratio
| 0.306 | 0.52 | 0.546 | 0.549 | 0.606 | 0.732 | 0.783 | 0.748 | 0.729 | 0.713 | 0.732 | 0.743 | 0.785 |
| Reseach & Development Expenses
| 17.041 | 84.587 | 77.564 | 43.659 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 124.508 | 107.854 | 90.028 | 86.225 | 101.779 | 39.609 | 3.043 | 36.181 | 66.411 | 47.622 | 26.421 | 29.216 | 38.782 |
| Selling & Marketing Expenses
| 29.456 | 10.215 | 23.322 | 27.411 | 59.513 | 92.504 | 68.471 | 45.62 | 27.943 | 2.75 | 5.614 | 2.924 | 5.26 |
| SG&A
| 403.554 | 118.069 | 113.35 | 113.636 | 161.292 | 132.113 | 3.043 | 81.801 | 94.354 | 50.371 | 32.035 | 32.14 | 44.042 |
| Other Expenses
| 466.902 | 379.365 | 11.19 | 14.511 | 10.498 | 10.779 | 4.262 | 0.049 | 1.242 | 2.61 | 0.574 | 0.626 | 0.058 |
| Operating Expenses
| 654.503 | 505.314 | 622.543 | 387.391 | 713.77 | 607.51 | 251.655 | 332.498 | 340.288 | 313.392 | 251.105 | 188.281 | 190.942 |
| Operating Income
| 1,016.514 | 945.179 | 721.156 | 879.709 | 735.525 | 1,713.357 | 2,352.536 | 1,816.228 | 1,697.055 | 1,545.006 | 1,472.34 | 1,319.932 | 1,496.015 |
| Operating Income Ratio
| 0.306 | 0.339 | 0.292 | 0.368 | 0.302 | 0.537 | 0.707 | 0.632 | 0.607 | 0.593 | 0.625 | 0.65 | 0.833 |
| Total Other Income Expenses Net
| 449.781 | 312.286 | 265.144 | 306.761 | 305.401 | 303.921 | -21.743 | 304.77 | 86.872 | 423.652 | 333.374 | 282.239 | 283.118 |
| Income Before Tax
| 1,466.295 | 1,257.465 | 986.3 | 1,186.47 | 1,040.926 | 2,017.278 | 2,330.793 | 2,120.997 | 1,783.927 | 1,968.657 | 1,805.714 | 1,602.171 | 1,496.015 |
| Income Before Tax Ratio
| 0.442 | 0.451 | 0.399 | 0.496 | 0.427 | 0.632 | 0.701 | 0.738 | 0.639 | 0.756 | 0.766 | 0.789 | 0.833 |
| Income Tax Expense
| 440.657 | 402.885 | 218.01 | 276.813 | 206.13 | 636.6 | 707.4 | 647.379 | 587.918 | 590.46 | 509.211 | 465.521 | 419.686 |
| Net Income
| 1,005.249 | 835.294 | 751.079 | 895.158 | 823.701 | 1,374.724 | 1,624.107 | 1,473.877 | 1,196.009 | 1,378.197 | 1,294.071 | 1,135.817 | 1,076.105 |
| Net Income Ratio
| 0.303 | 0.299 | 0.304 | 0.374 | 0.338 | 0.431 | 0.488 | 0.513 | 0.428 | 0.529 | 0.549 | 0.559 | 0.599 |
| EPS
| 33.77 | 28.17 | 25.45 | 30.38 | 27.96 | 46.66 | 54.57 | 50.16 | 41.14 | 47.53 | 44.96 | 39.78 | 37.69 |
| EPS Diluted
| 33.67 | 28.17 | 25.31 | 30.33 | 27.96 | 46.66 | 54.56 | 50.13 | 40.88 | 47.08 | 44.94 | 39.78 | 37.69 |
| EBITDA
| 1,121.343 | 1,429.838 | 1,068.008 | 1,186.239 | 977.754 | 1,624.921 | 2,307.074 | 1,650.386 | 1,807.359 | 1,703.082 | 1,341.479 | 1,229.052 | 1,099.082 |
| EBITDA Ratio
| 0.338 | 0.512 | 0.432 | 0.496 | 0.401 | 0.509 | 0.693 | 0.574 | 0.647 | 0.654 | 0.569 | 0.605 | 0.612 |